SEC Filing Summary for Evommune, Inc.

This filing details a Form 4 filed by Moss Gregory S., the Chief Business & Legal Officer of Evommune, Inc. On April 16, 2026, Mr. Moss was granted 115,279 employee stock options with a purchase price of $0.00. These options are exercisable for Evommune, Inc. Common Stock. The options vest over a period of 49 months, with one-fourth vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments thereafter, contingent upon continued service. The options have an expiration date of April 15, 2036. The filing also indicates a conversion or exercise price of $26.77 per share for the underlying common stock.